Eric Shaff
Chief Executive Officer at SERES THERAPEUTICS, INC.
Net worth: 100 544 $ as of 2023-07-30
Eric Shaff active positions
Companies | Position | Start | End |
---|---|---|---|
SERES THERAPEUTICS, INC. | Director/Board Member | 2019-01-14 | - |
Chief Executive Officer | 2019-01-14 | - | |
President | 2019-01-14 | - | |
Comptroller/Controller/Auditor | 2024-03-14 | 2024-03-24 | |
Chief Operating Officer | 2018-01-30 | 2019-01-14 | |
Director of Finance/CFO | 2024-03-14 | 2024-03-24 |
Career history of Eric Shaff
Former positions of Eric Shaff
Companies | Position | Start | End |
---|---|---|---|
SIGILON THERAPEUTICS, INC. | Director/Board Member | 2017-10-31 | 2023-08-10 |
Independent Dir/Board Member | 2017-10-31 | 2023-08-10 | |
MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2011-12-31 | 2014-10-31 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2004-05-31 | 2011-11-30 |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Broadview International LLC
Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Training of Eric Shaff
University of Pennsylvania | Undergraduate Degree |
Johnson Graduate School of Management | Masters Business Admin |
Statistics
International
United States | 9 |
Operational
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
SERES THERAPEUTICS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
SIGILON THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Broadview International LLC
Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Finance |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Eric Shaff
- Experience